JPMORGAN CHASE & CO - PYXIS ONCOLOGY INC ownership

PYXIS ONCOLOGY INC's ticker is and the CUSIP is 747324101. A total of 46 filers reported holding PYXIS ONCOLOGY INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of PYXIS ONCOLOGY INC
ValueSharesWeighting
Q3 2023$995
-91.0%
500
-88.4%
0.00%
Q2 2023$11,041
-44.8%
4,313
-14.3%
0.00%
Q1 2023$20,0000.0%5,033
+0.9%
0.00%
Q1 2022$20,000
-84.5%
4,986
-57.6%
0.00%
Q4 2021$129,00011,7690.00%
Other shareholders
PYXIS ONCOLOGY INC shareholders Q1 2023
NameSharesValueWeighting ↓
Yu Fan 69,303$137,9129.78%
Decheng Capital Management III (Cayman), LLC 326,810$650,3520.22%
Harvest Investment Services, LLC 113,894$226,6490.15%
Laurion Capital Management LP 3,170,803$6,309,8980.04%
CORNERCAP INVESTMENT COUNSEL INC 74,903$149,0570.03%
SCHULHOFF & CO INC 22,000$43,7800.02%
HHLR ADVISORS, LTD. 382,606$761,3860.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 236,195$470,0280.01%
ExodusPoint Capital Management, LP 415,072$8260.01%
Bleakley Financial Group, LLC 11,234$22,3560.00%
View complete list of PYXIS ONCOLOGY INC shareholders